115 results
SC TO-T
EX-99
Corerx Inc
11 Mar 24
Third party tender offer statement
4:05pm
”) with capabilities spanning pre-investigational new drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms … -to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global
8-K
EX-99.2
SCTL
Societal CDMO Inc
28 Feb 24
Form of Tender and Support Agreement
4:58pm
an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging
CoreRx … manufacturing, and a range of packaging services. The prospects for this combined entity to establish itself as a preferred CDMO partner in the small molecule
8-K
EX-99.1
xrg4e5z
8 Nov 23
Societal CDMO Reports Third Quarter 2023 Financial Results
4:11pm
8-K
EX-99.2
nirq8032 b56xl4aev
8 Nov 23
Societal CDMO Reports Third Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
9s5mema ict
20 Sep 23
Societal CDMO announces corporate restructuring
4:10pm
424B5
gsls0xl9hs830q8nt0iq
25 Aug 23
Prospectus supplement for primary offering
8:06pm
424B5
tmqzg22a69 rhhk
23 Aug 23
Prospectus supplement for primary offering
4:38pm
8-K
EX-99.1
kn4yeb auujjk60cbx
14 Aug 23
Societal CDMO Reports Second Quarter 2023 Financial Results
4:28pm
8-K
EX-99.2
j94s9 6mq8imgcz
14 Aug 23
Societal CDMO Reports Second Quarter 2023 Financial Results
4:28pm
8-K
EX-99.2
ccg0jqxpyb9bh w9
10 May 23
Societal CDMO Reports First Quarter 2023 Financial Results
4:22pm
8-K
EX-99.1
apiuk4v7
10 May 23
Societal CDMO Reports First Quarter 2023 Financial Results
4:22pm
424B5
yk29tw2t urr
13 Dec 22
Prospectus supplement for primary offering
5:29pm
424B5
aqt3m cavr7
13 Dec 22
Prospectus supplement for primary offering
5:26pm
424B5
t2submuv1d42
12 Dec 22
Prospectus supplement for primary offering
7:16am